Texas is contributing more to this year’s World Stem Cell Summit than simply its locale in San Antonio. The Genetics Policy Institute (GPI), the founders of the Summit, recently announced that the University of Texas Health Science Center at San Antonio is one of four major “organizing partners” that will spearhead the event. The other three partners include the Mayo Clinic, Kyoto University Institute for Integrated Cell-Material Sciences (iCeMS) and BioBridge Global.
Now in its 10th year, the Summit, which is set to take place from December 3-5, 2014, at the San Antonio Marriott Rivercenter in San Antonio, Texas, will seek to forge new guiding research goals for the stem cell science and regenerative medicine communities for the following year, with its four primary organizing partners leveraging their proven expertise in stem cell research and technology to guide the process.
For its part, the Texas biotech and life sciences communities have quickly become leaders in advancing critical research into stem cells and regenerative medicine. Recently, researchers at MD Anderson in Houston released data from a new study to target cancer stem cell drug resistance pathways. In the field of regenerative medicine, there are numerous research institutions in Texas currently working on major breakthroughs, such as a THI researcher working with Harvard Apparatus Regenerative Technology on growing new heart cells, and UT Medical Branch researchers at Texas Medical Center who have crafted human lungs in the lab.
These innovations, together with Texas’ ongoing development of its biotic and life sciences sector, is bound to serve as an exciting backdrop for the 2014 World Stem Cell Summit in San Antonio.
For more information about the Summit, visit http://www.worldstemcellsummit.com.